Interstitial Lung Diseases (ILD) are a group of over 200 disorders characterized by inflammation and/or scarring of the lung parenchyma. The Interstitial Lung Disease Program at the University of Calgary is a multidisciplinary program which provides clinical care, research, education, patient support, and patient advocacy for patients with ILD. The program was established in 2008 by Dr. Charlene D Fell.
|Dr. Charlene D Fell||Dr. Michael Bristow||Dr. Margaret Kelly||Mark Hyman, CCRP|
|Dr. Kerri Johannson||Dr. Paul Burrowes||Dr. Angela Franko|
|Dr. Sharon LeClercq||Dr. Tracy Elliot|
|Kirk Mathison, RN||Dr. Lancia Guo|
|Dr. Andrew Lee|
|Dr. Carmen Lydell|
|Dr. John Henry MacGregor|
The ILD Clinic at South Health Campus follows over 400 patients with a variety of interstitial lung diseases. New referrals are welcome through Pulmonary Central Access and Triage (PCAT). Dr. Charlene D Fell and Dr. Kerri Johannson provide subspecialty care in ILD and address questions of diagnosis, pharmacologic and non-pharmacologic management of ILD, and measures to improve the quality of life in ILD patients. 2 – 6 new patients are seen each week in the ILD Clinic. Monthly combined Pulmonary/Rheumatology Connective Tissue Disease (CTD)-ILD Clinics are held for complex patients with ILD due to underlying autoimmune disease. Referrals are triaged on a case-by-case basis for patients not routinely followed by a Rheumatologist (exceptions may be made on a case-by-case basis). Referrals to the CTD-ILD Clinic may be sent through PCAT. The ILD clinic has a dedicated ILD Nurse Clinician, Kirk Mathison, who provides education and support for patients during clinic and regular business hours.
ILD Multidisciplinary Diagnosis (MDD) Rounds are held every second week via Telehealth to review the clinical details, radiographic features, and histopathology of patients with ILD in order to finalize a diagnosis, plan further investigations, or guide treatment. Patients do not need to be seen in the ILD Clinic prior to being reviewed at ILD MDD Rounds (although this is preferred). To review your patient’s case at our MDD, please contact Dr. Kerri Johannson.
The ILD Program conducts physician- and resident- and industry-initiated research projects and participates in national and international research projects and therapeutic clinical trials. We are actively enrolling patients into the Canadian Registry for Pulmonary Fibrosis (CARE-PF) study and work with industry partners on phase 2, 3, and 4 clinical trials.
Publications from Drs. Fell and Johannson can be viewed via PubMed
Residents, fellows, and medical students who wish to work with either Drs. Fell or Johannson on a research project should contact the physicians directly.
The ILD Program provides education on the diagnosis and management of ILD to undergraduate medical students and residents training at the University of Calgary and to physicians and allied health care workers locally, nationally, and internationally. Our aim is to provide practical continuing medical education on ILD applicable to the everday practice of general practitioners and specialists. If you would like to attend a clinic with Drs. Fell or Johannson, please contact Ruby Leachman (email@example.com).
ILD Fellowship Program
This 12-24 month program provides in depth clinical training on the diagnosis and management of interstitial lung diseases, mentorship in clinical research, and mentorship on establishing a clinical program in ILD. Applicants must have obtained Royal College of Physicians and Surgeons of Canada (RCPSC) certification in Internal Medicine and must be on track to complete (or have obtained) RCPSC certification in Adult Respirology. Applicants must be eligible for licensure in Alberta (this requires completion of the Canadian Licentiate of Medical Council of Canada (LMCC) exams). Applications should be directed to Dr. Charlene Fell care of Ruby Leachman (firstname.lastname@example.org) and should include:
- Letter of intent
- 3 letters of support, one from the Respirology Training Program Director
Applications will be accepted until 5 pm on October 31 for Fellowships beginning on July 1 of the following year.
Visiting Pulmonary Fellow Electives
A one month elective is offered to Pulmonary Fellows currently enrolled in a RCPSC Pulmonary Fellowship Program in Canada. Please send a letter of intent, CV, and reference letter to Dr. Charlene Fell care of email@example.com.
PATIENT SUPPORT AND ADVOCACY
The University of Calgary ILD Program has a strong and very active Patient Support Group. The Calgary Pulmonary Fibrosis Support Group meets in the evening on the first Tuesday of the month (excluding July) at the East Calgary Health Centre. The meetings provide patients and their family members with information on topics of interest to the ILD community including pulmonary rehabilitation, living with supplemental oxygen, lung transplantation, advocacy, new scientific developments in ILD, and palliative care. These meetings are also available in Red Deer, Medicine Hat, and Lethbridge via Telehealth video conference. To receive more information on the support group and to join the email list, please contact Kirk Mathison (firstname.lastname@example.org).
The ILD Program is affiliated with the Pulmonary Fibrosis Society of Calgary (PFSC) and the Canadian Pulmonary Fibrosis Foundation (CPFF). We endorse the CPFF IPF Patient Charter. Members of our team participate in public awareness events and fundraising activities for the PFSC and the CPFF.